Who is sponsoring NCT05006144?

NCT05006144 is sponsored by Cairo University.

What drugs are being tested in NCT05006144?

Interventions in NCT05006144: physical therapy excercises, Standard Orthotic Management, selective dorsal rhizotomy.

What condition does NCT05006144 study?

NCT05006144 studies Bilateral Cerebral Palsy.

Is NCT05006144 still recruiting?

NCT05006144 is currently completed. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT05006144

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Selective Dorsal Rhizotomy on Non-ambulant Children With Bilateral Spastic Cerebral Palsy

Completed NA Last updated 13 April 2026

What this trial tests

NA trial testing physical therapy excercises in Bilateral Cerebral Palsy in 90 participants. Completed in 24 December 2025.

Timeline

10 August 2022

Primary endpoint
30 January 2024

24 December 2025

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	90
Start date	10 August 2022
Primary completion	30 January 2024
Estimated completion	24 December 2025
Sites	1 location across Egypt

Drugs / interventions tested

physical therapy excercises
Standard Orthotic Management
selective dorsal rhizotomy

Conditions studied

Bilateral Cerebral Palsy — all drugs for Bilateral Cerebral Palsy →

Sponsor

Cairo University

Who can join

Adults 4 to 7, any sex, with Bilateral Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children with spastic bilateral cerebral palsy are late developers. delayed gross and fine motor development require early intervention to improve the child performance and avoid secondary impairments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05006144 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006144.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing